Tuesday, April 2, 2019

Dictyostelium as a Predictive Model for Bitter Tastant

Dictyostelium as a prognosticative Model for Bitter TastantDeveloping Dictyostelium as a Predictive Model for Bitter Tastant IdentificationINTRODUCTIONBitter tastant ( barf) research utilises a variety of animal computer simulations for the identification of the barf susceptibility of impudent compounds and project to characterise the underlining mechanisms that give rise to emesis. there are two categories of animals use in this type of research, those that imbibe the ability to vomit (ferrets, dogs and cats), and those that lack the nauseant reflex (rats and mice) (Holmes et al., 2009). In addition to this, there is a different predisposition to vomit compounds amongst these animal forms, due to the existence of multiple channels for the emesis induction. There are too differences in the receptor pharmacology and distribution, and metabolic pathway regulation. This makes it very hard to use a unique animal model for emetic research, pushing research towards a multi-mode l shape up, therefore increasing the practice session of animals (Robery et al., 2011).Ingestion of rancour tastants can lead to innate aversive behaviour, decrease gastric emptying, nausea and vomiting in mammals and as such sulphurous tastants are thought to provide a rigidi ally vital ideal sign of toxicity (Robery et al., 2011).Humans recognise thousands of different compounds as sulphurous. patronage this ability only around 25 experiment 2 receptors (TAS2R) see been identified. Common rancour ligands include cycloheximide, denatonium, PROP (6-n-propyl-2-thiouracil), PTU (phenylthiourea), and -glucopyrano places (Meyerhof et al., 2010).As previously stated, bitter substances are detected by a specific subset of perceptivity receptors, cognise as BITTER TASTE-SENSING TYPE 2 receptors (TAS2Rs) (Meyerhof et al., 2010). These are part of the superfamily of G protein-coupled receptors (GPCRs) and can be found on carrell surface that interrupt gustatory taste perceptio n on the tongue. Signal transduction of bitter stimuli is staring(a) via the -subunit of gustducin (Gulbransen et al., 2009). This G protein subunit activates a taste phosphodiesterase and decreases cyclic nucleotide levels. The -subunit of gustducin also mediates taste by activating IP3 (inositol triphosphate) and DAG (diglyceride). These second messengers may free-spoken gated ion channels or may mother release of internal calcium. Although all TAS2Rs are located in gustducin-containing cells, knock issue of gustducin does non completely destroy sensitivity to bitter compounds, suggesting a redundant mechanism for bitter taste (unsurprising given that a bitter taste generally signals the presence of a toxin). One proposed mechanism for gustducin- autonomous bitter mouthful is via ion channel interaction by specific bitter ligands, like to the ion channel interaction which occurs in the tasting of sour and salty stimuli (Gulbransen et al., 2009).The properties of TAS2Rs ar e different from other GPCRs, because of the ability of fecundation a wide float of compounds with low specificity and affinity. TAS2Rs turn in recently been suggested to select important extra-oral functions in the respiratory and gastrointestinal tracts. In the human airline business epithelium TAS2Rs are expressed on the solitary chemo sensory(a) cells and ciliated epithelial cells, where they sense chemical irritation and promote ciliary beat frequency, respectively. therefrom TAS2Rs may be protective and part of the defence against inhaled noxious compounds (Zhang et al., 2013). young studies have found that in resting primary airway smooth vigour cells, bitter tastant activate TAS2R-dependent signalling pathway that results in an increase in Ca2+i levels, although to a level much lower than that cause by bronchoconstrictors (2-adrenoceptor friend) (Zhang et al., 2013).Under physiological circumstances, bitter tastants can activate TAS2Rs to modestly increase Ca2+i lev els without affecting contraction, but in the situation of muscle constriction, they can block L-type calcium channels to arrive at bronchodilation (Zhang et al., 2013).TAS2R agonists showed both greater relaxation and forbidding of airway hyper-responsiveness than a 2-adrenoceptor agonist in mouse airways. Given the large selection of known raw(a) and synthetic agonists recognized by the 25 TAS2Rs, the findings have introduced bitter taste receptors as a potential new family of targets for asthma pharmacotherapy (Zhang et al., 2013).Dictyostelium asa biomedical model organismD. Discoideum is a well-established research model organism, in particular in investigating chemotaxis. D. Discoideum is a social amoeba that feeds on bacterium as its staple food source. Once the food supply is exhausted, cells go about a victimisational program leading to the production of spores that are qualified to survive in hostile conditions (Frey et al., 2007). Starving cells produce a chemo-at tractant, cyclic AMP (cAMP), which serves as a signal for 1 x one hundred five neighbouring cells to aggregate, which thus develop into a mature fruiting body (after 24 hours), where 20% of the cells form a stalk that supports a spore head incorporating 80% of the remaining cells as spores. When food sources are avail adequate to(p) again, the spores germinate into amoebae, complete the life cycle (Figure 1) (Frey et al., 2007).(Frey et al., 2007)Figure 1 D. Discoideum, develops from a single vegetational amoebae (0hrs) through to the genesis of the mature fruiting body (24hrs). Aggregation is ca employ by the chemotaxis of cells toward cAMP waves to give rise to a multicellular aggregate. Aggregation results in the creation of a mound, then a tipped mound, and as development proceeds, the tip prolongate and forms a finger. Ultimately, the finger collapses to form a slug or continues to form a fruiting body. During final stage of the development, the cells differentiate into va cuolated stalk cells that sustain a spore head containing spores, which can tolerate a wider range of environmental conditions. The full developmental process from starvation of vegetive cells to the formation of a mature fruiting body is accomplished in 24 h (Frey et al. 2007).D. Discodeum has been extensively utilised to investigate a range of fundamental biological processes such as cell migration, signal transduction, phagocytosis and signalling during morphogenesis and cell differentiation.The fully sequenced genome contains 34 Mb of DNA (84-fold smaller than the human genome). D. Discoideum has a genome that encodes for a variety of proteins that are human homologues, associated with a variety of dis ordinates (Boeckeler et al., 2007). Therefore, it has been suggested that the primary role of those proteins can be analysed in the model to understand their related to dis vagabond function.Nausea and vomiting are common but skillful side effects associated with many therapeu tic drugs. Whilst the physiological mechanisms behind the generation of the vomiting response are well characterised, the diverse range of emetic stimuli that can generate the response are poorly understood. The potential of employ D. Discoideum, a eukaryotic amoeba, as a model for predicting emetic indebtedness was examined in this thesis. The effects of a diverse range of known emetic and aversive compounds on Dictyostelium cell behaviour was investigated, resulting in the identification of a small number that strongly suppress cell behaviour in a concentration-dependent manner.Recent studies development Dictyostelium as a simple model system for bitter related (emetic) research has shown the validity of using this approach for the reduction of animals in testing for emetic liability. Even though Dictyostelium does not contain genes encoding homologues to T2R proteins associated with bitter compounds detecting, it has been identified the molecular(a) mechanism creditworthy of PTU detection. The screening of mutants resistant to the effects of PTU on growth identified a putative G-protein coupled receptor mutant, GrlJ-.Translation of this discovery to human consideration identified an uncharacterised human gamma-aminobutyric acid (GABA) type B isoform, with a comparatively weak homology to GrlJ. The expression of the human GABA-B receptor restored GrlJ- sensitivity to PTU, implicating this human protein as a novel receptor for PTU. In addition, GrlJ only partially controls PTU detection but not detection for all bitter substances.This research was carried out by monitoring the cell behaviour (motility, circularity, protrusions formation and displacement) following icon to a range of known emetic compounds. Results show that bitter tastants cause an acute, marked and concentration dependent effect on cell behaviour.Therefore, this suggests that Dictyostelium may guarantee a new model for the analysis and screening of novel bitter/emetic compounds, and t herefore reducing the utilisation of animal models by identifying the best candidates in a range of molecules.In this study a range of eight compounds were tested to investigate their effects on Dictyostelium random cell movement. The compounds list was specifically created to understand if the model system was able to predict the bitterness of those compounds and ultimately obtain a ranking order comparable to the in vivo rat brief access taste crime (BATA) and human sensory panel models (Rudnitskaya, et al., 2013). The set of substances consisted of both organic and inorganic azelastine, caffeine, chlorhexidine, potassium nitrate, paracetamol, quinine and sumatriptan.Results have shown that the bitterness ranking order obtained by using random cell movement assays was comparable to the one obtained with the BATA and the human sensory panel models.In particular, amongst those compounds, Azelastine, a selective (non-sedating) H1 antagonist structurally similar to other anti-histam inic molecules has shown to be one of the most potent compounds in the inhibition of Dictyostelium cell behaviour. This bitter-tasting compound is pharmacologically classified as a 2gen antihistamine, with coitus lack of CNS (central nervous system) activity. Clinical trials, in vitro and in vivo studies have shown the combined effect of direct inhibition and stabilisation of inflammatory cells.In vitro studies suggest that the affinity of azelastine for H1 receptors is several times higher than that of chlorpheniramine, a 1gen H1 antagonist. Azelastine right off antagonizes TNF-, leukotrienes, endothelin-1, and platlet-activating factor.In vivo studies in a guinea pig model have demonstrated that both histamine-related and h-independent bronchoconstriction were inhibited by azelastine (Williams et al., 2010).The second most potent compound tested is Chlorhexidine (CHX), a broad spectrum antimicrobial agent, frequently used in dental-care to inhibit bacterial growth and in arrest ontal disease prophylaxis. It is classified as antibacterial, but it can also interfere with the proteolytic activity of some periodontal pathogens. This inhibitory effect is associated with its chelating properties (Trufello et al., 2014).One of the chemicals used as standard for bitterness measurements is Quinine, a natural occurring alkaloid with different healthful properties, such as antipyretic, antimalarial, analgesic, and anti-inflammatory activities.MethodsD. discoideum discoideum maintenanceCells and spores were stored at -80 C, and every month an aliquot of the frozen stock was collected and placed on a Raoutella planticola bacterial lawn. After 3-4 days, plaques of growth were visible, which were then scraped and transferred into liquid dishes. Culture dishes were unbroken in absolute sterile conditions at the constant temperature of 21 C. Cells essential for experiments were transferred into shake cultures (120 rpm/min) or water-washed off every 2 days. In order to make vibration cultures, cells were washed off the plate, transferred to a G0 media (Ax medium containing 100/ml Penicillin and 100g/ml Streptomicin), and unbroken in the shaking incubator at 21 C and counted and or diluted every day. Cells were utilised for experiments after 2-3 days of shaking and flasks were kept for one week before replacing them with fresh cultures. The liquid circumscribe in flasks was 1/5 of the total flask volume, in order to maintain ideal growth conditions (oxygen and surface area), and they were be kept between 2 and 5 x 106. breeding assayDictyostelium development assays were performed in triplicate experiments. Cells were plated onto membranes at the concentration of 1 x 107 per membrane (in KK2), then the membranes were transferred onto millipore filters embedded with the selected drug. Cells were placed in small petri dishes (6 cm diameter) and kept at 22 C for 24 hours in humid environmental conditions. Development images were taken after 24 hou rs at different magnification resolutions (x2, x3.2, and x4 side at 45-degree angle).D. discoideum Permanent stockAt least 1 x 107 cells were collected from fresh culture plate, and resuspendend in 200l D. discodeum freeze medium (7% DMSO, Horse serum), and frozen to -80C using isopropanol freezing containers for two hours, then stored at -80 C in liquid nitrogen. receive cell microscopyTo prepare D. discodeum cells (Ax2) for behaviour analysis experiments, cells were grown in shaking suspension in Axenic medium (Formedium Co. Ltd, Norfolk, UK) for at least 48hrs. Cells were washed and resuspended in phosphate buffer at 1.7 x 106 cells/ml. Cells were then pulsed for 5 hours with 30 nM cAMP at 6 min intervals whilst shaking at 120 rpm. Cells were then washed in phosphate buffer, resuspended at 1.7105 cells/ml, and 250 L aliquots of cells were added to into a Lab-Tek 8-well chambered coverglass wells (Thermo Fisher, Leicestershire, UK), and allowed to adhere for 10-15 min, and for e ach experiment double concentrated drugs (250 l) were administrated at the 15th frame by using a P1000. Cells movement was investigated using an Olympus IX71 microscope at 40X magnification, and images were recorded with a QImaging RetigaExi Fast1394 digital camera. Images were acquired every 15 seconds over a 15 min period for each compound, and at each concentration, with a minimum of three independent experiments for each drug/concentration and an average cell number of 10 cells quantified per experiment. Solvent only controls were carried out for all experiments to ensure readouts were based upon compounds listed, with for example, no effect of DMSO shown at 1% the highest concentration used in the experiments draw here.ReferencesAyana Wiener Marina Shudler Anat Levit Masha Y. Niv. BitterDB a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue)D413-419.Bachmanov AA, Beauchamp GK (2007). appreciation Receptor Genes. yearbook Review of Nutrition 27 389414.C hoi, D.H. et al., 2013. Evaluation of taste-masking effects of pharmaceutical sweeteners with an electronic tongue system. Drug development and industrial pharmacy, 9045, pp.110. on hand(predicate) at http//www.ncbi.nlm.nih.gov/pubmed/23786206 Accessed October 10, 2013.Finger, T.E. Kinnamon, S.C., 2011. Taste isnt just for taste buds anymore. F1000 biology reports, 3(September), p.20. unattached at http//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3169900tool=pmcentrezrendertype= abstract entity Accessed December 9, 2013.Finger, T.E. Kinnamon, S.C., 2011. Taste isnt just for taste buds anymore. F1000 biology reports, 3(September), p.20. obtainable at http//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3169900tool=pmcentrezrendertype=abstract Accessed December 9, 2013.Gulbransen, B. D., Clapp, T. R., Kinnamon, S. C., Finger, T. E. (2009). NIH Public Access, 99(6), 29292937. doi10.1152/jn.00066.2008.NasalHolmes, a M., Rudd, J. a, Tattersall, F. D., Aziz, Q., Andrews, P . L. R. (2009). Opportunities for the second-stringer of animals in the study of nausea and vomiting. British Journal of Pharmacology, 157(6), 86580. doi10.1111/j.1476-5381.2009.00176.xMargolskee, R.F., 2002. molecular(a) mechanisms of bitter and sweet taste transduction. The Journal of biological chemistry, 277(1), pp.14. obtainable at http//www.ncbi.nlm.nih.gov/pubmed/11696554 Accessed December 4, 2013.Meyerhof, W. et al., 2010. The molecular receptive ranges of human TAS2R bitter taste receptors. chemical substance senses, 35(2), pp.15770.Available at http//www.ncbi.nlm.nih.gov/pubmed/20022913 Accessed October 17, 2013.Pulkkinen, V. et al., 2012. The bitter taste receptor (TAS2R) agonists denatonium and chloroquine viewing unmistakable patterns of relaxation of the guinea pig trachea. American journal of physiology. Lung cellular and molecular physiology, 303(11), pp.L95666.Available at http//www.ncbi.nlm.nih.gov/pubmed/22962016 Accessed September 19, 2013.Pulkkinen, V. et al. , 2012. The bitter taste receptor (TAS2R) agonists denatonium and chloroquine display distinct patterns of relaxation of the guinea pig trachea. American journal of physiology. Lung cellular and molecular physiology, 303(11), pp.L95666.Available at http//www.ncbi.nlm.nih.gov/pubmed/22962016 Accessed September 19, 2013.Robery, S. et al., 2011. Investigating the effect of emetic compounds on chemotaxis in Dictyostelium identifies a non-sentient model for bitter and hot tastant research. PloS one, 6(9), p.e24439. Available at http//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3169598tool=pmcentrezrendertype=abstract Accessed October 10, 2013.Rudnitskaya, A. et al., 2013. Assessment of bitter taste of pharmaceuticals with multisensor system employing 3 way PLS regression. Analytica chimica acta, 770, pp.4552.Available at http//www.ncbi.nlm.nih.gov/pubmed/23498685 Accessed October 10, 2013.Ueda, T. et al., 2003. Functional interaction between T2R taste receptors and G-protein alpha subunits expressed in taste receptor cells. The Journal of neuroscience the ordained journal of the Society for Neuroscience, 23(19), pp.737680.Available at http//www.ncbi.nlm.nih.gov/pubmed/12917372.Wiener, A. et al., 2012. BitterDB a database of bitter compounds. Nucleic acids research, 40(Database issue), pp.D4139.Available at http//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3245057tool=pmcentrezrendertype=abstract Accessed October 17, 2013.Williams, P.B., Crandall, E. Sheppard, J.D., 2010. Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of supersensitive conjunctivitis. Clinical Ophthalmology, p.993. Available at http//www.dovepress.com/azelastine-hydrochloride-a-dual-acting-anti-inflammatory-ophthalmic-so-peer-reviewed-article-OPTH Accessed February 3, 2014.Zhang, C.-H., Lifshitz, L. M., Uy, K. F., Ikebe, M., Fogarty, K. E., ZhuGe, R. (2013). The cellular and molecular basis of bitter tastant-induced bronchodilation. PLo S Biology, 11(3), e1001501. doi10.1371/journal.pbio.1001501Available at http//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3589262tool=pmcentrezrendertype=abstract Accessed October 15, 2013.Trufello, a M. et al., 2014. Subclinical concentrations of chlorhexidine inhibit gelatinase activity of carious dentine in vitro. Australian dental journal, pp.16.Available at http//www.ncbi.nlm.nih.gov/pubmed/24494744 Accessed February 10, 2014.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.